Peptide Works
Research-Grade Peptides
Peptide Works
Research-Grade Peptides
A research peptide supplier built around verified purity, lot-specific documentation and plain, honest answers supporting laboratories, universities and independent researchers worldwide.
Peptide Works supplies high-purity research peptides to laboratories, universities, and independent researchers around the world. Readers looking for a concise overview of the company’s mission, standards, and operating approach can visit Peptide Works about us. The rest of this page explains how we work and why the details matter more than they might appear to at first glance.
We are a supplier, not a research institution. We don't run studies, publish findings, or make claims about what any compound does. What we do is source, verify, store, document, and ship peptides that arrive matching the specification on the label, with the paperwork to prove it. Everything supplied by Peptide Works is intended for laboratory research and development purposes only.
If you have bought research peptides before, you already know the failure modes. A vial arrives with no certificate. The certificate arrives but it's undated, unsigned, or copied across an entire product line rather than tied to the lot in your hand. The purity figure is quoted to two decimal places by a supplier who can't tell you which method produced it. Support goes quiet the moment the payment clears. Nobody advertises those problems, and yet almost everyone in this field has run into them.
Peptide Works exists because those problems are solvable. They are not solved by slogans. They are solved by testing every batch, by keeping documentation attached to the specific lot it describes, by packing for stability rather than for speed, and by answering messages after the order has shipped as readily as before it. None of that is glamorous. All of it is the job.
We would rather be judged on the certificate of analysis than on the wording of this page.
Peptide Works started with a straightforward observation: in research peptide supply, the gap between the best suppliers and the worst is enormous, and from the outside the two look almost identical.
Both have clean websites. Both use the word "purity" often. Both mention third-party testing somewhere. But one of them can send you a certificate of analysis, dated, lot-numbered, with an HPLC chromatogram attached and the name of the laboratory that ran it. The other sends a PDF that has been floating around since 2019, reused across half a dozen products, with a lot number that doesn't correspond to anything.
A researcher receiving a vial has almost no way to tell them apart until the material is already in an experiment. By then, the cost of being wrong is not the price of the vial. It's the run. It's the reagents consumed alongside it. It's the week spent chasing a result that turns out to be an artefact of a compound that wasn't what the label said it was. In the worst cases, it's a set of conclusions that quietly rests on a foundation nobody checked.
That asymmetry — where the buyer carries all the risk and the supplier carries none of it — is what Peptide Works was set up to close. Not by promising more than anyone else, but by making the evidence available up front so the buyer doesn't have to take anything on trust.
The early work was unglamorous. Identifying manufacturing partners whose analytical data survived scrutiny, and declining the ones whose didn't. Establishing a relationship with independent laboratories willing to test our material on our schedule rather than at our convenience. Working out cold-chain packaging that actually holds temperature across a long-haul customs delay, rather than packaging that looks reassuring on the doorstep. Writing documentation that a chemist would find useful instead of documentation that a marketing team would find quotable.
Some of it we got wrong the first time. Our initial packaging specification was adequate for short domestic routes and marginal on long international ones, and we changed it after seeing enough transit data to know we were relying on luck. We have adjusted lead-time estimates more than once because our early ones were optimistic in a way that wasn't fair to customers planning around them. We would rather say that plainly than pretend the process arrived fully formed.
What has not changed is the principle underneath it. A research supplier's product is not really the peptide. It's the confidence that the peptide is what the label says. Everything else — the catalogue, the shipping, the support — is built on top of that, and collapses without it.
To supply researchers with peptides of consistent, verified purity, supported by documentation they can actually use and service they don't have to chase.
That is the whole of it. We have deliberately not written a mission statement that gestures at transforming science or shaping the future, because we are not doing either of those things. Our customers are doing those things. Our job is to make sure that a small, unglamorous, easily overlooked part of their work — the material arriving correctly — is one thing they don't have to worry about.
In practice that mission breaks down into commitments we can be held to:
Every lot in the Peptide Works catalogue has been tested and has documentation tied to it. Not tested at some point in the product's history. Tested as the lot you will receive.
Purity figures come with a method attached. If a peptide tests at 98.4%, that is what the certificate says. We do not round upward, and we do not quote a specification where a result belongs.
If something is delayed, we say so, and we say why. If a compound is out of stock, we don't take the order and hope. If a question is outside what we can properly answer, we say that too rather than improvising.
The relationship does not end when the tracking number is issued. It ends when the material has arrived, been checked, and been found satisfactory — and if it hasn't, it hasn't ended at all.
Mission statements are cheap. These are the specific things you can hold Peptide Works to, and the only reasonable test of whether we mean them is whether we do them consistently when it's inconvenient.
We want Peptide Works to be the supplier researchers reorder from without thinking about it.
That sounds modest. It isn't. Becoming the default is one of the hardest positions to earn, because it can't be bought with a discount or a redesign. It is earned by being unremarkable in the right way, repeatedly, over years — by the tenth order arriving with the same purity, the same documentation, and the same packaging integrity as the first.
A researcher who has to re-evaluate their supplier before every purchase is spending attention that belongs to their actual work. The end state we are aiming at is one where that evaluation stops being necessary. Where a lab manager places a Peptide Works order the way they order pipette tips: with a reasonable expectation that the thing will arrive, that it will be right, and that if it isn't, someone will pick up.
We are also aiming at something slightly larger than our own customer base. Standards in research peptide supply tend to rise when buyers start expecting more and stop tolerating vague answers. Every supplier that publishes real batch-level data makes it marginally harder for suppliers that don't. If Peptide Works contributes to that, and to a market where a certificate of analysis is the baseline rather than a differentiator, that is a good outcome regardless of who the customer eventually buys from.
Trust in this field is slow to build and fast to lose. We would rather grow at the speed trust allows.
The Peptide Works catalogue is broad, and it is organised around formats as much as around compounds. Different research contexts call for different presentations of the same material, and the format affects handling, storage, and stability in ways that are worth understanding before you order.
The standard presentation, and the one most research applications call for. Lyophilisation — freeze-drying — removes water from the peptide under vacuum, leaving a dry solid that is far more stable than the same material in solution. A properly lyophilised peptide, stored cold and sealed, has a shelf life measured in years rather than weeks.
The visual appearance of a lyophilised peptide varies more than people expect. Some form a neat white cake that fills the base of the vial. Others collapse into a thin film against the glass, or appear as a scatter of translucent flakes that can look, to an unfamiliar eye, like the vial is nearly empty. This is a function of the peptide's own physical properties and the lyophilisation cycle, not a sign of a problem or a shortfall in quantity. Mass is confirmed by weight, not by how much of the vial the solid appears to occupy. It is one of the most common questions we get from researchers new to peptides, and the answer is almost always that the vial is fine.
Multiple peptides combined into a single vial at fixed ratios. These exist for practical reasons: fewer vials to store, fewer reconstitution steps, fewer opportunities for handling error, and a fixed ratio that doesn't drift between preparations.
The trade-off is inflexibility. A blend commits you to a ratio, and if a protocol needs that ratio changed, the blend cannot accommodate it. Blends also complicate analysis, because a certificate for a blend must account for each component, and the interaction of components under storage is a further variable. They suit established, repeated work. They suit exploratory work less well. We stock them because researchers ask for them, and we are clear about where they help and where a single-compound vial is the more sensible choice.
An oral-format presentation, held to the same purity standards as the rest of the catalogue and supplied, like everything else, strictly for research purposes. Capsules simplify handling and storage relative to vials — no reconstitution, no sterile technique — but they involve an excipient matrix, and any format with a matrix requires the certificate to speak to the peptide content specifically rather than the capsule as a whole. Ours do.
Supplied as pre-formulated solutions in a spray delivery bottle. The Peptide Works Vitamin B12 listing is one example of a nasal spray presentation provided strictly for research purposes. The chemistry here is meaningfully different from the dry vial, because the material is already in solution and therefore already subject to the degradation pathways that solution invites: hydrolysis, oxidation, aggregation, and adsorption onto container surfaces. Stability testing on these formats has to account for the formulation, the buffer, the preservative system, and the container, not just the principal material.
That makes them shorter-lived than lyophilised material, and we say so on the documentation rather than quoting a shelf life that assumes ideal conditions. Cold storage is not optional for these; it is the condition under which the stated stability holds.
Peptide supplied in solution within a pen-style device, calibrated for repeatable metered dispensing. The appeal is consistency across repeated draws and a reduction in preparation steps. The same solution-stability considerations that apply to nasal sprays apply here, with the added variable of the device: the internal materials, the seal, and the mechanism all contribute to how the contents hold up over time.
Bacteriostatic water, sterile filtered water, syringes, alcohol swabs, and the consumables that accompany peptide handling in a laboratory. Nothing exotic. We stock them because a researcher who has to source them separately, from a supplier whose quality control they have not assessed, has introduced an uncontrolled variable into their own workflow for no good reason.
We decline compounds where the analytical data does not satisfy us, where synthesis at reliable purity is not achievable at the scale requested, or where the supply chain is opaque enough that we cannot vouch for provenance. This shortens the catalogue relative to some competitors. We are comfortable with that. A catalogue is only as good as its weakest listing, and a supplier who will list anything is telling you something about how they assess everything.
This is the section that matters, and it is the section most suppliers write in the vaguest terms. We will be specific instead.
Peptide Works works to a purity threshold of 99% or above for the majority of our catalogue. For structurally complex peptides — longer sequences, peptides with difficult residues, cyclic structures, or those carrying modifications — the threshold is 98% or above.
That distinction is not a hedge. It reflects the chemistry. Solid-phase peptide synthesis builds a sequence one amino acid at a time, and each coupling step is efficient but not perfect. A tiny per-step shortfall, compounded across a long sequence, produces a population of closely related impurities — deletion sequences missing a residue, truncated chains, incompletely deprotected fragments — that are chemically similar to the target and therefore difficult to separate from it. For a short, simple peptide, 99%+ is routinely achievable. For a long or awkward one, insisting on 99%+ across the board would mean either not stocking it or quoting a number the data doesn't support.
We have chosen to stock it and tell the truth about it. A supplier who quotes 99%+ on every product in a diverse catalogue is either working with a narrower definition of purity than they've disclosed, or is not being straight with you.
Every lot Peptide Works supplies has a certificate of analysis tied to it. Not to the product line. To the lot.
That distinction is the single most useful thing in this section, so it's worth dwelling on. A certificate of analysis is a record of what a specific batch of material was found to contain when a specific laboratory tested it on a specific date. It is not a general statement about the product. If a supplier's certificate has no lot number, or has a lot number that doesn't match the vial, or is the same PDF that came with an order two years ago, then whatever it is, it isn't evidence about your material.
A certificate that means something will show you:
The lot or batch number, matching the vial in your hand. If these don't correspond, nothing else on the document is relevant to you.
The date of analysis. Peptides degrade. A certificate from four years ago describes the material as it was four years ago, which is useful context and nothing more.
The analytical methods used, named. Typically HPLC for purity and mass spectrometry for identity. A purity percentage with no stated method is a number without a provenance.
The purity result, as measured — not as specified. There is a meaningful difference between "specification: ≥99%" and "result: 99.3%". The first is an aspiration. The second is a measurement. Certificates that only display the specification are, intentionally or otherwise, telling you nothing about your batch.
The mass spectrometry result, showing the observed molecular weight against the theoretical value for the sequence. This is the identity check. Purity tells you the sample is homogeneous; mass spec tells you it's homogeneously the right thing.
The chromatogram itself, where available. A percentage is a summary. The trace is the evidence. A clean chromatogram with a single dominant peak and a flat baseline tells you something a number cannot, and so does a messy one.
The name of the laboratory and, ideally, a signature or analyst reference.
We supply certificates with this content because we would want them ourselves. Product-specific pages, including the Peptide Works GHK-Cu Peptide listing, can also provide access to relevant analytical documentation such as certificates of analysis and HPLC data. If anything on a Peptide Works certificate is unclear, ask us and we will walk you through it.
Our material is tested by independent laboratories with no commercial interest in the result.
Internal quality control is necessary — every serious manufacturer runs it — but it is not sufficient, for the obvious reason that a manufacturer testing its own output has an interest in what the test says. Third-party verification removes that conflict. The laboratory has no stake in whether a batch passes. It reports what it observes.
This is a real cost and a real delay. Batches wait on external results. Occasionally an external result contradicts an internal one, and when that happens, the external result wins and the batch does not ship. That has happened. It will happen again. It is the entire point of the arrangement — a verification system that never rejects anything is not a verification system, it is theatre.
High-performance liquid chromatography (HPLC) separates the components of a sample by pushing it through a column packed with a stationary phase. Different molecules interact with that phase differently and therefore emerge at different times. The detector records what comes out and when, producing a chromatogram: a baseline with peaks rising from it, each peak a component of the sample.
Purity, in this context, is the area of the target peak expressed as a percentage of the total area of all peaks. A 99% result means the target compound accounts for 99% of the detected material. It is worth being precise about what that does and does not mean. It means 99% of what the detector saw at that wavelength under those conditions. It does not account for residual solvents, counter-ions, or water content, which are separate measurements. Nobody in the field is hiding this; it is simply what the number means, and knowing what a number means is a prerequisite for using it.
Mass spectrometry ionises the sample and measures mass-to-charge ratio, producing an observed molecular weight to compare against the theoretical weight calculated from the sequence. A match confirms identity. A mismatch — particularly one offset by the mass of a single amino acid — points to a deletion sequence, which is exactly the impurity that solid-phase synthesis is prone to producing.
The two together do the job neither can do alone. HPLC without mass spec tells you the sample is pure without telling you what it's pure of. Mass spec without HPLC tells you the right compound is present without telling you how much else is present alongside it.
Purity is a snapshot. Stability is what happens afterwards, and it is where a great many well-made peptides are ruined by everything that follows synthesis.
Peptides degrade through several routes. Hydrolysis, where water attacks the peptide bond. Oxidation, which particularly affects methionine, cysteine, and tryptophan residues. Deamidation of asparagine and glutamine. Aggregation, where molecules associate into structures that no longer behave like the monomer. Adsorption, where peptide simply sticks to the walls of its container and quietly leaves solution.
Every one of these is accelerated by heat, by moisture, by light, and by time in solution. Which is why lyophilised material stored cold and sealed is stable for years, and the same peptide reconstituted and left on a bench is a different proposition entirely.
Peptide Works stores material under refrigeration or freezing as the compound requires, sealed against moisture ingress, protected from light where the sequence warrants it, and with stock rotated so that nothing sits indefinitely on the assumption that cold storage stops the clock. It slows the clock. It does not stop it.
Every unit we ship carries a lot number that traces back through our records to the synthesis batch, the analytical documentation, the storage history, and the date it entered our inventory.
This exists for one reason: if something goes wrong, we need to know precisely what else is affected. A supplier who cannot trace a problem to a batch has only two options when a problem surfaces — recall everything, or recall nothing. Both are bad. Traceability is the difference between an issue that gets contained in a day and an issue that quietly propagates through a dozen laboratories because nobody could establish which vials shared a parent.
You will most likely never need this. It is there for the case where you do.
Support is where suppliers reveal themselves, because it is the only part of the operation that costs money and generates none.
Anyone can be responsive during a sale. The question is what happens two weeks later, when the material has arrived, the payment has cleared, and you have a question that will take somebody twenty minutes to answer properly and will produce no additional revenue.
At Peptide Works, that question gets answered.
We will tell you what is actually in stock, rather than taking an order and sorting it out afterwards. We will give you a lead time we believe, rather than the one that closes the sale. If a compound is on backorder, you will hear that before you pay, not after.
We will send you the certificate of analysis for the current lot before you buy, if you ask. Some suppliers treat this as an unusual request. It should be the standard one. You are being asked to trust a purity figure; it is entirely reasonable to want to see the document behind it first.
We will also tell you when we are not the right supplier for something. If you need a compound we don't stock, or a purity grade we can't reliably hit, or a quantity that doesn't make sense for us to fulfil, we will say so. Sending someone elsewhere costs us an order. Taking an order we can't fulfil properly costs us a customer.
You get a tracking number when the parcel ships, and you get an actual human if the tracking stops updating. International shipments do stall — customs holds happen, and they happen to well-documented, entirely compliant parcels for reasons that are often opaque. What we can do is tell you what we can see, chase the carrier, and be honest about the timeline rather than repeating that it's "on its way" until it either arrives or doesn't.
This is the part that counts.
If your vial looks wrong, contact us. If the lyophilised material looks like less than you expected, contact us — as noted above, this is usually the cake structure rather than a shortfall, but you should not have to guess.
If you can't locate the certificate, we will resend it. If you want the raw chromatogram rather than the summary, we will look for it. If you have a question about how a certificate should be read, we will explain it, and we won't make you feel like you should have known.
If the material genuinely isn't right, we will make it right. Not after an argument. Not after you have proven a negative. If a Peptide Works product doesn't meet the specification we sold it under, that is our problem to solve, and the fastest way to solve it is usually to replace the material and investigate afterwards rather than the other way round.
We will not advise you on how to use these products, because they are supplied for laboratory research only, and telling you how to use them would be both outside our competence and outside what is permitted. We will not interpret results for you. We will not recommend one compound over another for a purpose, because doing so would mean making claims about effects, and we do not make claims about effects.
That boundary is firm, and it is not evasion. It is the line between a supplier who is being careful and one who is not. A supplier who will happily tell you what a research compound does for a given purpose is a supplier who has stopped taking the research-use-only designation seriously, and you should ask yourself what else they have stopped taking seriously.
Peptide Works ships internationally, to most countries. Shipping a temperature-sensitive biological material across borders is the part of this business with the most failure points, and it deserves a plain account rather than a reassuring one.
Peptides ship cold. Ours are packed with insulation and coolant sized to the route, not to a single generic standard, because a two-day domestic shipment and a nine-day international one with an unpredictable customs stop are not the same problem and should not receive the same box.
Vials are packed to survive handling that is rougher than anyone would like to imagine. Glass in transit is glass in transit, and the failure mode is not usually a dramatic drop but the slow accumulation of vibration and pressure over a long haul. Padding, rigid outer packaging, and vials that are not free to move against one another are how that gets prevented.
We also pack against moisture, because a peptide that has been kept beautifully cold and has quietly absorbed atmospheric water through a compromised seal is not in better condition than one that got warm.
Every order gets tracking. Where available and appropriate to the route, we use carriers whose handling of temperature-sensitive goods is something they've actually thought about rather than something they mention on a webpage.
Delivery estimates are estimates. Domestic routes are predictable. International routes are predictable until they aren't, and the variable is almost always customs rather than the carrier. We give you the honest range rather than the best case.
We offer shipping protection on orders. It covers the material against loss and against damage in transit. It exists because, over enough shipments, some parcels go wrong through nobody's fault, and the researcher at the end of that chain should not be the one absorbing the cost of a carrier's mistake.
It is optional, and whether it makes sense depends on the value of the order and the route. We would rather explain it than upsell it.
Here is the part that other suppliers tend to bury.
Research peptides are regulated differently in different jurisdictions. A compound that moves freely into one country may be restricted, controlled, or prohibited in another. Import rules change, and they change without much notice.
Peptide Works ships in compliance with the requirements applicable to us, and we document shipments accurately. What we cannot do is determine whether a specific compound may lawfully be imported into your specific country by you, in your specific circumstances. That determination is yours, and it has to be, because we are not in a position to know your regulatory context or your institutional permissions.
Customs may hold, inspect, delay, or refuse a shipment. Where that happens for reasons within our control — documentation, declaration, packaging — we will fix it and bear the cost. Where it happens because a compound is not permitted entry to your jurisdiction, that is not something we can resolve on your behalf, and we would rather you know that clearly now than discover it from a customs notice.
If you are uncertain about the rules where you are, check before you order. We would genuinely rather lose the sale than have you receive a notice.
Values, as normally written, are nouns with no consequences attached. Here are the four that shape decisions at Peptide Works, described by what we actually do about them.
We do not state a purity figure we cannot show you the data for. We do not describe a compound's effects, because we have not established them and it is not our place to. When a customer asks a question we can't answer with evidence, the answer is "we don't know" — which is unsatisfying, and correct, and infinitely better than an invented figure delivered confidently.
The practical cost of this is that our marketing is duller than our competitors'. We accept that trade.
The most consequential decisions we make are the ones where we say no. No to a manufacturing partner whose analytical package doesn't hold up under questioning. No to a batch that came back from external testing below specification, even when it is close, even when the stock is needed, even when the margin on the write-off hurts. No to a compound that would sell well and that we cannot properly stand behind.
A supplier that has never turned down a profitable batch has not yet been tested. Every quality system is a set of promises until the first time it costs you something.
Delays get communicated. Backorders get disclosed before payment, not after. Limits on what we can advise on get stated plainly rather than fudged. The regulatory responsibilities that sit with you get spelled out rather than buried in terms nobody reads.
Some of this loses orders. A customer who walks away because we told them the lead time was three weeks rather than one is a customer we didn't disappoint.
We answer questions from customers whose orders arrived months ago and who are not currently buying anything. We resend certificates. We explain chromatograms. We do this because a supplier whose attention tracks the payment is not a supplier, it's a transaction, and researchers can tell the difference immediately.
We will not tell you we're the best. Every supplier says that, it costs nothing to say, and you have no way to check it. Here instead are the specific reasons customers give us, which you can verify yourself.
The documentation stands up. Lot-specific certificates, with methods named, dated, independently produced, and with the chromatogram available. Ask any supplier for the certificate of the current lot before you buy. What comes back — and how quickly, and how willingly — tells you most of what you need to know about them.
The purity figures are honest, including when they're inconvenient. 99%+ on the majority of the catalogue. 98%+ on structurally complex peptides, stated openly rather than concealed behind a blanket claim. If a batch tests at 98.6%, the certificate says 98.6%.
Consistency across orders. The tenth vial matches the first. That is unremarkable when it happens and catastrophic when it doesn't, and it is only achievable through batch-level testing that never gets skipped because a shipment is running late.
Someone answers. Before the order, during transit, and — the part that separates suppliers — long after delivery, when there is nothing in it for us.
Global reach with honest caveats. We ship to most countries, we pack for the route rather than for appearances, we offer shipping protection, and we tell you plainly which parts of the customs process sit with you rather than pretending they don't exist.
Boundaries we don't cross. We will not tell you what these compounds do for a given purpose, because they are research materials and that is not a claim we are willing or permitted to make. If that is a disadvantage relative to suppliers who will, we're comfortable with it. So, in our experience, are serious researchers.
All products listed on this website and supplied by Peptide Works are intended for laboratory research and development purposes only.
They are not for human or animal consumption, ingestion, or administration of any kind. They are not medicines, supplements, cosmetics, or foodstuffs, and they are not supplied as any of those things.
The information, statements, and products presented on this website are provided for research and educational purposes only. Nothing here is intended to diagnose, treat, cure, or prevent any condition, and nothing here should be read as a claim that any product has any physiological, therapeutic, or other effect.
Purchasers are responsible for handling these materials in accordance with appropriate laboratory practice, for holding whatever institutional approvals and regulatory permissions apply to their work, and for determining whether a given compound may lawfully be imported into and possessed within their jurisdiction. Peptide Works cannot make that determination on a purchaser's behalf.
By purchasing from Peptide Works, you confirm that you are acquiring these materials for laboratory research purposes only, and that you accept responsibility for their lawful handling, storage, and use in that context.
All products offered through Peptide Works are strictly for research and laboratory use only. They are not intended for human or animal consumption, ingestion, or therapeutic application. The information, data and materials presented are for scientific analysis and academic purposes solely and are not intended to diagnose, treat, cure or prevent any illness or medical condition.